z-logo
open-access-imgOpen Access
Interface between Pharmacoepidemiology and Pharmacoeconomics in Managed Care Pharmacy
Author(s) -
Lon N. Larson,
Darrel C. Bjornson
Publication year - 1996
Publication title -
journal of managed care pharmacy
Language(s) - English
Resource type - Journals
eISSN - 1944-706X
pISSN - 1083-4087
DOI - 10.18553/jmcp.1996.2.3.282
Subject(s) - pharmacoeconomics , medicine , pharmacoepidemiology , pharmacy , health care , health economics , intensive care medicine , population , pharmaceutical care , economic evaluation , family medicine , pharmacology , public health , medical prescription , nursing , environmental health , pathology , economics , economic growth
OBJECTIVE: To review precepts of and practical examples for pharmacoepidemiology and pharmacoeconomics. DATA SOURCES: Recent clinical and management literature. STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: Consistent with health care goals of the individual patient, the goal of rational drug therapy in a large beneficiary population covered by an integrated health system requires evaluation of clinical options at both the individual and population levels. Pharmacoepidemiology and pharmacoeconomics provide the tools to perform such analyses. From the discipline of pharmacoepidemilogy, the distribution of diseases and related effects on medication use, both beneficial and adverse, are determined for patient populations. Pharmacoeconomics builds upon these data and provides the methods with which to place economic and quality of life value on those exposures. CONCLUSION: Using the disciplines of pharmacoepidemiology and pharmacoeconomics, the health care provider can gain...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom